Read more Treatment information Product Name: Wegovy Manufacturer: Novo Nordisk Active Ingredient(s): Semaglutide Administration: Subcutaneous injection Presentation: Injectable solution Available Strength: 0.25, 0.5, 1.0, 1.7, 2.4, 7.2 mg Exemption: Prescription Only Dosage: Once a week Description: Wegovy is a weekly injection that aids weight loss Drug Class: GLP-1 analogue Alcohol Consumption: Avoid or limit alcohol consumption When Pregnant: Do not take Wegovy if you are pregnant Price: 109.99 GBP Image: Click here to view the Wegovy - Patient Information Leaflet Authored By Leanne is a science and health content writer focusing on human health and biology while utilising her solid academic background
If formula-feeding, restart can occur sooner
Competing interests The authors declare that they have no competing interests
Site schematic select a zone Hover or focus a zone to read its function
Subcutaneous injections offer significantly superior bioavailability compared to topical application, allowing GHK-Cu to reach deeper tissue layers and exert systemic effects that benefit not only the skin but also hair follicles and broader tissue remodeling internally
With obesity becoming a global problem, the potential for market growth is considerable